Benchmark reaffirms Andersons stock rating citing growth initiatives By Investing.com

Benchmark reiterated a Buy on The Andersons (ANDE) with a $90 price target versus a $70.40 share price, implying meaningful upside. The firm cited internal growth initiatives, a stabilizing agricultural economy, and strength in the ethanol sector, with EPS projected to nearly triple from mid-2025 levels by 2029. Recent results were mixed but supportive overall, with Q1 EPS of $1.12 beating the $0.52 consensus even as revenue missed at $2.63 billion versus $2.69 billion expected.

Analysis

The market is treating ANDE less like a cyclical ag name and more like a self-help compounder, but that re-rating creates its own fragility. If the earnings bridge to 2029 is real, the upside is not in a one-quarter beat; it's in multiple expansion plus operating leverage from better asset utilization, which is why the stock can keep outperforming even if top-line growth remains lumpy. The second-order implication is that the market may start capitalizing ANDE against a much steadier mid-cycle earnings stream, which tends to pull valuation away from spot commodity optics and toward execution quality.

The key risk is that the thesis depends on two things moving together: a stable farm economy and persistent ethanol margin support. Those are not independent—if crop economics weaken, ethanol blending economics usually get more competitive, but if energy prices fall sharply or policy expectations shift, the ethanol leg can de-rate quickly. That makes this a slower-burn trade over months, not days; the first sign of trouble would be management commentary on margin normalization or capex intensity rising faster than earnings conversion.

What the consensus may be missing is that a “good” operational story can already be mostly in the price after a near-doubling, especially when the market has to underwrite forward growth several years out. The asymmetry now is less about upside surprise and more about disappointment risk if EPS growth is front-loaded but not durable. In other words, ANDE looks investable, but the easier money may have already been made unless the next two quarters confirm that the improvement is translating across multiple business lines, not just one favorable spread environment.

Key Decisions for Investors

• Maintain a tactical long ANDE, but size it smaller than a fresh entry: use a 3-6 month horizon and treat pullbacks toward the low-$70s as better risk/reward than chasing strength. Upside remains if execution confirms the 2026-2027 earnings ramp, but the stock likely needs continued proof to justify much higher multiples.
• Pair ANDE long against a basket of higher-beta agribusiness or ethanol names with weaker visibility over the next 2-4 quarters. The goal is to isolate the execution premium while reducing exposure to a broader ag-cycle fade.
• For accounts able to use options, consider a call spread rather than outright stock: upside is still available, but implied re-rating risk after a strong run makes defined-risk convexity preferable over the next 2-6 months.
• Do not add aggressively ahead of the next earnings print unless channel checks confirm margin durability. If the next report shows revenue softness persisting without incremental margin expansion, expect the market to compress the multiple quickly.
• Watch for evidence that capex or working-capital needs are rising faster than EBITDA conversion; that would be the earliest tell that the story is becoming capital-intensive rather than compounding.